Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2012 Jan 01;712:e51516. doi: 10.1371/journal.pone.0051516.
Show Gene links
Show Anatomy links
High yield production and refolding of the double-knot toxin, an activator of TRPV1 channels.
Bae C
,
Kalia J
,
Song I
,
Yu J
,
Kim HH
,
Swartz KJ
,
Kim JI
.
???displayArticle.abstract???
A unique peptide toxin, named double-knot toxin (DkTx), was recently purified from the venom of the tarantula Ornithoctonus huwena and was found to stably activate TRPV1 channels by targeting the outer pore domain. DkTx has been shown to consist of two inhibitory cysteine-knot (ICK) motifs, referred to as K1 and K2, each containing six cysteine residues. Beyond this initial characterization, however, the structural and functional details about DkTx remains elusive in large part due to the lack of a high yielding methodology for the synthesis and folding of this cysteine-rich peptide. Here, we overcome this obstacle by generating pure DkTx in quantities sufficient for structural and functional analyses. Our methodology entails expression of DkTx in E. coli followed by oxidative folding of the isolated linear peptide. Upon screening of various oxidative conditions for optimizing the folding yield of the toxin, we observed that detergents were required for efficient folding of the linear peptide. Our synthetic DkTx co-eluted with the native toxin on HPLC, and irreversibly activated TRPV1 in a manner identical to native DkTx. Interestingly, we find that DkTx has two interconvertible conformations present in a 1∶6 ratio at equilibrium. Kinetic analysis of DkTx folding suggests that the K1 and K2 domains influence each other during the folding process. Moreover, the CD spectra of the toxins shows that the secondary structures of K1 and K2 remains intact even after separating the two knots. These findings provide a starting point for detailed studies on the structural and functional characterization of DkTx and utilization of this toxin as a tool to explore the elusive mechanisms underlying the polymodal gating of TRPV1.
???displayArticle.pubmedLink???
23240036
???displayArticle.pmcLink???PMC3519854 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 2. Expression of DkTx in E. coli.SDS-PAGE gels (15%) were stained with Coomassie Blue. Lane M, molecular weight markers (kDa); lane T, total cell lysate; lane P, pellet fraction; lane S, soluble fraction.
Figure 3. Purification and activity of the DkTx folding product.(A) Purification of linear DkTx. Cleavage of the fusion protein and reduction of the disulfide bond were accomplished using hydroxylamine and DTT, respectively, as described in methods. (B) Linear DkTx was folded in 1 M NH4OAc (pH 8.0) buffer containing 1 M GdnHCl, 1 mM EDTA, 2.5 mM GSH and 0.25 mM GSSG for 5 days at 4°C. The toxins were purified using a linear gradient of 29–44% solvent B for 15 min at a flow rate of 14 ml/min, where solvent A was water containing 0.1% TFA and solvent B was acetonitrile containing 0.1% TFA. (C) Fraction 5 activated TRPV1 expressed in oocytes. Holding voltage was −60 mV.
Figure 4. HPLC profiles of DkTx during the folding reaction.The peptides were separated using a linear gradient of 5–65% solvent B for 30 min at a flow rate of 1 ml/min, where solvent A was water containing 0.1% TFA and solvent B was acetonitrile containing 0.1% TFA. (A) Oxidative folding of DkTx in redox buffer was monitored by HPLC. Asterisks indicate correctly folded DkTx. (B) HPLC chromatogram of purified DkTx. Dashed and solid arrows indicate the minor and major forms of DkTx, respectively. (C) The minor form was collected and re-injected after 75 min. (D) The major form was collected and re-injected after 175 min. (E) Co-injection of native and synthetic DkTx.
Figure 5. Folding kinetics of K1, K2 and DkTx.(A) HPLC chromatograms showing the folding of DkTx, K1 and K2. The left panel depicts the linear toxins. Arrows indicate correctly folded forms of the toxins. The toxins were eluted with a linear gradient of 5–65% solvent B for 30 min at a flow rate of 1 ml/min, where solvent A was water containing 0.1% TFA and solvent B was acetonitrile containing 0.1% TFA. (B) Comparison of folding kinetics of DkTx, K1 and K2. At each time point, aliquots were withdrawn and acidified by adding acetic acid. Quantification of the folding specifies was accomplished using HPLC. The correctly folded form (%) was determined based on the areas of the HPLC peaks. The curves represent fits of the data to a one-phase association.
Figure 6. Activity of K1, K2 and DkTx on TRPV1 channels.(A) Synthetic K1, K2 and DkTx activate TRPV1 channels. Oocytes were held at −60 mV and toxins were added to the recording chamber. (B) Concentration-dependence for activation of TRPV1 by the toxins.
Figure 7. CD spectra of K1, K2 and DkTx.The CD spectra were recorded in 0.01 M sodium phosphate (pH 7.0) at 20°C. K1+K2 depicts the added values of the CD spectra from K1 and K2.
Adams,
Agatoxins: ion channel specific toxins from the American funnel web spider, Agelenopsis aperta.
2004, Pubmed
Adams,
Agatoxins: ion channel specific toxins from the American funnel web spider, Agelenopsis aperta.
2004,
Pubmed
Adams,
Two classes of channel-specific toxins from funnel web spider venom.
1989,
Pubmed
Andreev,
Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1).
2008,
Pubmed
,
Xenbase
Bohlen,
A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain.
2010,
Pubmed
,
Xenbase
Bornstein,
Cleavage at Asn-Gly bonds with hydroxylamine.
1977,
Pubmed
Bulaj,
Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides.
2008,
Pubmed
Corzo,
Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.
2002,
Pubmed
DeLa Cruz,
Detergent-assisted oxidative folding of delta-conotoxins.
2003,
Pubmed
Escoubas,
Structure and pharmacology of spider venom neurotoxins.
2000,
Pubmed
Fletcher,
The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider.
1997,
Pubmed
Gomes,
Nigriventrine: a low molecular mass neuroactive compound from the venom of the spider Phoneutria nigriventer.
2011,
Pubmed
Hong,
Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA.
1995,
Pubmed
Isbister,
Spider bite.
2011,
Pubmed
Jung,
Solution structure and lipid membrane partitioning of VSTx1, an inhibitor of the KvAP potassium channel.
2005,
Pubmed
Kim,
Hydroxyl group of Tyr13 is essential for the activity of omega-conotoxin GVIA, a peptide toxin for N-type calcium channel.
1994,
Pubmed
Kim,
Tyr13 is essential for the activity of omega-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers.
1995,
Pubmed
Kim,
Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers.
1995,
Pubmed
Kitaguchi,
An inhibitor of TRPV1 channels isolated from funnel Web spider venom.
2005,
Pubmed
,
Xenbase
Kobayashi,
Three-dimensional solution structure of omega-conotoxin TxVII, an L-type calcium channel blocker.
2000,
Pubmed
Lee,
Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating.
2004,
Pubmed
,
Xenbase
Nicholson,
Modification of sodium channel gating and kinetics by versutoxin from the Australian funnel-web spider Hadronyche versuta.
1994,
Pubmed
Pi,
Soluble expression, purification and functional identification of a disulfide-rich conotoxin derived from Conus litteratus.
2007,
Pubmed
Raussens,
Protein concentration is not an absolute prerequisite for the determination of secondary structure from circular dichroism spectra: a new scaling method.
2003,
Pubmed
Rudolph,
In vitro folding of inclusion body proteins.
1996,
Pubmed
Ruta,
Functional analysis of an archaebacterial voltage-dependent K+ channel.
2003,
Pubmed
Saez,
Spider-venom peptides as therapeutics.
2010,
Pubmed
Sasaki,
Synthesis, bioactivity, and cloning of the L-type calcium channel blocker omega-conotoxin TxVII.
1999,
Pubmed
Siemens,
Spider toxins activate the capsaicin receptor to produce inflammatory pain.
2006,
Pubmed
Steiner,
Optimization of oxidative folding methods for cysteine-rich peptides: a study of conotoxins containing three disulfide bridges.
2011,
Pubmed
Stemmer,
Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.
1995,
Pubmed
Swartz,
An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula.
1995,
Pubmed
Wang,
Molecular surface of tarantula toxins interacting with voltage sensors in K(v) channels.
2004,
Pubmed
,
Xenbase
Zhan,
A fusion protein of conotoxin MVIIA and thioredoxin expressed in Escherichia coli has significant analgesic activity.
2003,
Pubmed
Zhang,
Expression and preparation of recombinant hepcidin in Escherichia coli.
2005,
Pubmed
